During an undergraduate year in Southern India, Kurt Reynertson researched the changing dynamics of agricultural practices that followed the Green Revolution and became fascinated with the pragmatic use of plants, especially traditional medicinal plants. As a doctoral student at the City University of New York, he studied plant science (Phytochemistry) under the mentorship of Dr. Edward Kennelly. His dissertation research focused on the isolation and structural elucidation of bioactive natural products from a group of edible fruits in the plant family Myrtaceae, and resulted in numerous peer-reviewed publications and a patent for a new anti-inflammatory natural product with potential for use in COPD therapy.

As a postdoctoral fellow in the lab of Pharmacology Chair Dr. Lorraine Gudas (Weill Cornell Medical College), he worked on the identification of natural products with potential to induce embryonic stem cell differentiation for potential cancer stem cell therapy. He also studied Clinical Epidemiology in collaboration with Dr. Mary Charlson as a Fellow of the Center for Complementary and Integrative Medicine.As a student and postdoc, he was continuously supported by NIH and Department of Defense fellowship awards for a decade.

In 2011, he joined the Naturals Platform in the Skincare Innovation group of Johnson & Johnson Consumer Companies, where he worked on early discovery of natural ingredients. More recently, he turned his extensive ingredient expertise towards developing ingredient polices and managing regulatory intelligence as a member of the Global Consumer Regulatory and Stewardship Policy team.
Education
Ph.D. in Plant Science (Phytochemistry), City University of New York
M.S. in Clinical Epidemiology, Weill Cornell Medical College
B.A. in Philosophy, University of Wisconsin